Reports for FRESENIUS KABI CANADA LTD

Company Name

FRESENIUS KABI CANADA LTD

Totals

Shortage reports

310

Actual shortage: 12 (4%)
Anticipated shortage: 1 (0%)
Avoided shortage: 5 (2%)
Resolved: 292 (94%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

48 (15%)

Overdue reports

4 (31%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP 2MG SOLUTION Resolved 2022-05-15 2022-08-09 160653
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP 2MG SOLUTION Resolved 2022-09-01 2022-10-02 168499
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP 2MG SOLUTION Resolved 2023-01-16 2023-05-01 181139
VORICONAZOLE FOR INJECTION 200MG POWDER FOR SOLUTION Resolved 2022-02-08 2022-12-04 154479
ERTAPENEM FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2022-02-08 2022-09-21 154473
LEVOTHYROXINE SODIUM INJECTION 40MCG SOLUTION Resolved 2022-11-03 2023-03-10 173469
LEVOTHYROXINE SODIUM INJECTION 100MCG SOLUTION Resolved 2022-11-03 2023-03-02 173475
FENTANYL CITRATE INJECTION, USP 50MCG SOLUTION Resolved 2022-10-02 2023-01-16 170878
FENTANYL CITRATE INJECTION, USP 50MCG SOLUTION Resolved 2023-08-03 2023-08-31 201035
FENTANYL CITRATE INJECTION, USP 50MCG SOLUTION Resolved 2023-10-03 2023-11-17 205907

Showing 301 to 310 of 310

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0